Volume 7, Issue 3 (7-2013)                   Qom Univ Med Sci J 2013, 7(3): 1-10 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Akbarpour M. The Effect of Resistance Training on Serum Levels of Adipokine and Inflammatory Markers of Cardiovascular Disease in Obese Men. Qom Univ Med Sci J 2013; 7 (3) :1-10
URL: http://journal.muq.ac.ir/article-1-140-en.html
University of Qom , akbarpour.mohsen@gmail.com
Abstract:   (6379 Views)

Background and Objectives: Recent studies on endocrine function have revealed many pathological complications in relation to obesity and metabolic diseases. Thus, the present study was carried out with the aim of investigating the effect of 12-week resistance training on the serum levels adipokine (adiponectin and leptin) and inflammatory markers of cardiovascular diseases in obese men. Methods: In this semi-experimental study, 20 non-athlete obese men were randomly assigned to two groups of experimental and control. The experimental group performed the resistance training protocol, three sessions per week for 12 weeks, while the control group was prohibited to do training program during the research implementation. Five ml of venous blood was taken from the participants at the beginning of the sixth week and at the end of the twelfth week to measure leptin, adiponectin, CRP, IL-6, and TNF-α. The significance level was considered to be >α0.05. Results: Resistance training caused decrease in CRP (p=0.002), IL-6 (p=0.001) and leptin (p=0.002), and increase in adiponectin (p=0.001) in the experimental group compared to the control group. Also, TNF-α level showed a decrease in the experimental group after 12 weeks of resistance training, which was not statically significant. Conclusion: The results of this study showed that regular resistance trainings reduce the potential risk of cardiovascular diseases via improvement of the plasma levels of adiponectin, leptin, CRP, and IL-6, and it can be used as an effective nonpharmacological treatment to prevent these diseases.  

Full-Text [PDF 219 kb]   (3532 Downloads)    
Type of Study: Original Article |
Received: 2016/02/13 | Accepted: 2016/02/23 | Published: 2016/02/23

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Qom University of Medical Sciences Journal

Designed & Developed by : Yektaweb